Streamline Health So (STRM) 1.50 $STRM
Evolent Health Hits New 52 Week High, Valence Buy the Key
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 2:51PM CDT
Shares of Evolent Health Inc (EVH) scaled a new 52-week high of $23.64 on Jul 14.
FMI: 23.19 (-0.53), EVH: 23.66 (-0.03), STRM: 1.50 (-0.02), OMCL: 38.02 (-0.74)
Evolent Health (EVH) Buys Valence for $145M, Shares Surge
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 7:22AM CDT
Shares of Evolent Health (EVH) surged almost 20% to close at $22.35 on Jul 13, after the company announced that it is acquiring Chicago-based Valence Health.
BOX: 11.63 (-0.24), EVH: 23.66 (-0.03), STRM: 1.50 (-0.02), OMCL: 38.02 (-0.74)
Streamline Health® Reports First Quarter 2016 Revenues of $6.7 Million; Adjusted EBITDA of $0.6 Million; $1.5 Million Net Loss
PR Newswire - Wed Jun 08, 3:01PM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced financial results for the first quarter of fiscal 2016, which ended April 30, 2016.
STRM: 1.50 (-0.02)
Streamline Health® To Report First Quarter 2016 Financial Performance On June 8, 2016
PR Newswire - Tue May 31, 8:00AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced that it will release its first quarter 2016 financial performance for the period that ended April 30, 2016, on Wednesday, June 8, 2016.
STRM: 1.50 (-0.02)
Streamline Health® Reports Fourth Quarter And Fiscal Year 2015 Financial Performance
PR Newswire - Wed Apr 20, 4:00PM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced financial results for the fourth quarter and fiscal year of 2015, which ended January 31, 2016.
STRM: 1.50 (-0.02)
Streamline Health® To Report Fourth Quarter And Fiscal Year 2015 Financial Performance
PR Newswire - Wed Apr 13, 8:45AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced that it will release its fourth quarter and fiscal year 2015 financial performance for the period that ended January 31, 2016, on Wednesday, April 20, 2016.
STRM: 1.50 (-0.02)
Streamline Health® Appoints Shaun Priest In Newly Created Position Of Chief Growth Officer
PR Newswire - Mon Apr 11, 8:00AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced the appointment of Mr. Shaun Priest as Senior Vice President and Chief Growth Officer, effective April 6, 2016. Mr. Priest will report directly to David Sides, President and Chief Executive Officer, Streamline Health.
STRM: 1.50 (-0.02)
athenahealth Crushes Q4 Earnings Estimate, Revenues Meet
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 10:30AM CST
athenahealth Inc. (ATHN) reported earnings of 45 cents per share in the fourth quarter of 2015, well ahead of the Zacks Consensus Estimate of 16 cents.
STRM: 1.50 (-0.02), CPSI: 38.86 (-0.68), OMCL: 38.02 (-0.74), ATHN: 124.68 (-3.92)
Edwards Lifesciences (EW) Likely to Top Earnings Again in Q4
Zacks Equity Research - Zacks Investment Research - Fri Jan 29, 12:31PM CST
Last quarter, Edwards Lifesciences (EW) had delivered a positive earnings surprise of 10.20%.
GILD: 80.14 (-0.32), ADHD: 4.22 (-0.09), EW: 113.53 (-0.70), STRM: 1.50 (-0.02)
Streamline Health's Enterprise Scheduling And Resource Management Solution Named 2015/2016 Category Leader In Best In KLAS®
PR Newswire - Thu Jan 28, 8:16AM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, today announced that its Looking Glass® Enterprise Scheduling and Resource Management solution was named Category Leader in the 2015/2016 Best in KLAS report published earlier today by KLAS. This makes 13 years in a row that it has been the highest ranked solution in its category.
STRM: 1.50 (-0.02)
Will Myriad Genetics Q2 Earnings (MYGN) Surprise Investors?
Zacks Equity Research - Zacks Investment Research - Wed Jan 27, 12:55PM CST
Last quarter, Myriad Genetics (MYGN) had delivered a positive earnings surprise of 17.14%
MYGN: 30.49 (-0.99), GILD: 80.14 (-0.32), STRM: 1.50 (-0.02), ARAY: 5.42 (-0.03)
Will Thermo Fisher (TMO) Surprise Q4 Earnings Expectations?
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 11:40AM CST
Thermo Fisher Scientific, Inc. (TMO) is slated to report its fourth-quarter 2015 earnings numbers before the opening bell on Jan 28.
GILD: 80.14 (-0.32), TMO: 156.86 (-2.70), STRM: 1.50 (-0.02), ARAY: 5.42 (-0.03)
Why Q4 Earnings Beat is Dicey at Quest Diagnostics (DGX)
Zacks Equity Research - Zacks Investment Research - Mon Jan 25, 1:05PM CST
Quest Diagnostics Inc. (DGX) is scheduled to report its fourth-quarter 2015 earnings results before the opening bell on Jan 28, 2016.
GILD: 80.14 (-0.32), DGX: 85.10 (-1.14), STRM: 1.50 (-0.02), ARAY: 5.42 (-0.03)
Medidata: Clinical Cloud Uptake & Client Base on the Rise
Zacks Equity Research - Zacks Investment Research - Thu Jan 21, 12:20PM CST
Medidata Solutions (MDSO) continues to win clients for its Sunrise platform.
MDSO: 52.77 (-0.71), STRM: 1.50 (-0.02), OMCL: 38.02 (-0.74), ATHN: 124.68 (-3.92)
Allscripts' (MDRX) Sunrise EHR Demand Continues to Rise
Zacks Equity Research - Zacks Investment Research - Thu Jan 21, 10:50AM CST
Allscripts Healthcare Solutions (MDRX) recently announced that its Sunrise platform has been selected as an Electronic Health Record system by Tuba City Regional Health Care Corporation.
STRM: 1.50 (-0.02), MDRX: 14.00 (-0.21), OMCL: 38.02 (-0.74), ATHN: 124.68 (-3.92)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Streamline Health Solutions, Inc. -- STRM
PR Newswire - Thu Jan 14, 11:34AM CST
Levi & Korsinsky announces it has commenced an investigation of Streamline Health Solutions, Inc. (NASDAQCM: STRM) concerning possible breaches of fiduciary duty by the board of directors of the company. To obtain additional information, go to:
STRM: 1.50 (-0.02)
Allscripts Q4 Bookings Likely to Hit Record Levels, Stock Up
Zacks Equity Research - Zacks Investment Research - Wed Jan 13, 12:00PM CST
Allscripts (MDRX) expects fourth-quarter bookings to cross the all-time high of $327 million recorded in fourth-quarter 2011.
STRM: 1.50 (-0.02), MDRX: 14.00 (-0.21), OMCL: 38.02 (-0.74), ATHN: 124.68 (-3.92)
Evolent Health Hits New 52 Week High, Valence Buy the Key
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 2:51PM CDT
Shares of Evolent Health Inc (EVH) scaled a new 52-week high of $23.64 on Jul 14.
FMI: 23.19 (-0.53), EVH: 23.66 (-0.03), STRM: 1.50 (-0.02), OMCL: 38.02 (-0.74)
Evolent Health (EVH) Buys Valence for $145M, Shares Surge
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 7:22AM CDT
Shares of Evolent Health (EVH) surged almost 20% to close at $22.35 on Jul 13, after the company announced that it is acquiring Chicago-based Valence Health.
BOX: 11.63 (-0.24), EVH: 23.66 (-0.03), STRM: 1.50 (-0.02), OMCL: 38.02 (-0.74)
Streamline Health® Reports First Quarter 2016 Revenues of $6.7 Million; Adjusted EBITDA of $0.6 Million; $1.5 Million Net Loss
PR Newswire - Wed Jun 08, 3:01PM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced financial results for the first quarter of fiscal 2016, which ended April 30, 2016.
STRM: 1.50 (-0.02)
Streamline Health® To Report First Quarter 2016 Financial Performance On June 8, 2016
PR Newswire - Tue May 31, 8:00AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced that it will release its first quarter 2016 financial performance for the period that ended April 30, 2016, on Wednesday, June 8, 2016.
STRM: 1.50 (-0.02)
Streamline Health® Reports Fourth Quarter And Fiscal Year 2015 Financial Performance
PR Newswire - Wed Apr 20, 4:00PM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced financial results for the fourth quarter and fiscal year of 2015, which ended January 31, 2016.
STRM: 1.50 (-0.02)
Streamline Health® To Report Fourth Quarter And Fiscal Year 2015 Financial Performance
PR Newswire - Wed Apr 13, 8:45AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced that it will release its fourth quarter and fiscal year 2015 financial performance for the period that ended January 31, 2016, on Wednesday, April 20, 2016.
STRM: 1.50 (-0.02)
Streamline Health® Appoints Shaun Priest In Newly Created Position Of Chief Growth Officer
PR Newswire - Mon Apr 11, 8:00AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced the appointment of Mr. Shaun Priest as Senior Vice President and Chief Growth Officer, effective April 6, 2016. Mr. Priest will report directly to David Sides, President and Chief Executive Officer, Streamline Health.
STRM: 1.50 (-0.02)
athenahealth Crushes Q4 Earnings Estimate, Revenues Meet
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 10:30AM CST
athenahealth Inc. (ATHN) reported earnings of 45 cents per share in the fourth quarter of 2015, well ahead of the Zacks Consensus Estimate of 16 cents.
STRM: 1.50 (-0.02), CPSI: 38.86 (-0.68), OMCL: 38.02 (-0.74), ATHN: 124.68 (-3.92)
Edwards Lifesciences (EW) Likely to Top Earnings Again in Q4
Zacks Equity Research - Zacks Investment Research - Fri Jan 29, 12:31PM CST
Last quarter, Edwards Lifesciences (EW) had delivered a positive earnings surprise of 10.20%.
GILD: 80.14 (-0.32), ADHD: 4.22 (-0.09), EW: 113.53 (-0.70), STRM: 1.50 (-0.02)
Streamline Health's Enterprise Scheduling And Resource Management Solution Named 2015/2016 Category Leader In Best In KLAS®
PR Newswire - Thu Jan 28, 8:16AM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, today announced that its Looking Glass® Enterprise Scheduling and Resource Management solution was named Category Leader in the 2015/2016 Best in KLAS report published earlier today by KLAS. This makes 13 years in a row that it has been the highest ranked solution in its category.
STRM: 1.50 (-0.02)
Will Myriad Genetics Q2 Earnings (MYGN) Surprise Investors?
Zacks Equity Research - Zacks Investment Research - Wed Jan 27, 12:55PM CST
Last quarter, Myriad Genetics (MYGN) had delivered a positive earnings surprise of 17.14%
MYGN: 30.49 (-0.99), GILD: 80.14 (-0.32), STRM: 1.50 (-0.02), ARAY: 5.42 (-0.03)
Will Thermo Fisher (TMO) Surprise Q4 Earnings Expectations?
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 11:40AM CST
Thermo Fisher Scientific, Inc. (TMO) is slated to report its fourth-quarter 2015 earnings numbers before the opening bell on Jan 28.
GILD: 80.14 (-0.32), TMO: 156.86 (-2.70), STRM: 1.50 (-0.02), ARAY: 5.42 (-0.03)
Why Q4 Earnings Beat is Dicey at Quest Diagnostics (DGX)
Zacks Equity Research - Zacks Investment Research - Mon Jan 25, 1:05PM CST
Quest Diagnostics Inc. (DGX) is scheduled to report its fourth-quarter 2015 earnings results before the opening bell on Jan 28, 2016.
GILD: 80.14 (-0.32), DGX: 85.10 (-1.14), STRM: 1.50 (-0.02), ARAY: 5.42 (-0.03)
Medidata: Clinical Cloud Uptake & Client Base on the Rise
Zacks Equity Research - Zacks Investment Research - Thu Jan 21, 12:20PM CST
Medidata Solutions (MDSO) continues to win clients for its Sunrise platform.
MDSO: 52.77 (-0.71), STRM: 1.50 (-0.02), OMCL: 38.02 (-0.74), ATHN: 124.68 (-3.92)
Allscripts' (MDRX) Sunrise EHR Demand Continues to Rise
Zacks Equity Research - Zacks Investment Research - Thu Jan 21, 10:50AM CST
Allscripts Healthcare Solutions (MDRX) recently announced that its Sunrise platform has been selected as an Electronic Health Record system by Tuba City Regional Health Care Corporation.
STRM: 1.50 (-0.02), MDRX: 14.00 (-0.21), OMCL: 38.02 (-0.74), ATHN: 124.68 (-3.92)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Streamline Health Solutions, Inc. -- STRM
PR Newswire - Thu Jan 14, 11:34AM CST
Levi & Korsinsky announces it has commenced an investigation of Streamline Health Solutions, Inc. (NASDAQCM: STRM) concerning possible breaches of fiduciary duty by the board of directors of the company. To obtain additional information, go to:
STRM: 1.50 (-0.02)
Allscripts Q4 Bookings Likely to Hit Record Levels, Stock Up
Zacks Equity Research - Zacks Investment Research - Wed Jan 13, 12:00PM CST
Allscripts (MDRX) expects fourth-quarter bookings to cross the all-time high of $327 million recorded in fourth-quarter 2011.
STRM: 1.50 (-0.02), MDRX: 14.00 (-0.21), OMCL: 38.02 (-0.74), ATHN: 124.68 (-3.92)
